AbbVie News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

16.10.14	AbbVie Board Recommends Stockholders Vote Against Shire Deal - Quick Facts (RTTNews)
15.10.14	Shire Plunges As AbbVie Reconsiders Offer Recommendation (RTTNews)
15.10.14	Shire Believes AbbVie Should Proceed With Recommended Offer - Quick Facts (RTTNews)
15.10.14	AbbVie To Reconsider Shareholder Recommendation On Inversion Deal For Shire (RTTNews)
14.10.14	ABBV Seeks New Cures From Old Drug, RARE Findings, Nanosphere Makes Giant Leap (RTTNews)
13.10.14	AbbVie Reports Late-Breaking Results From Phase 3 Trial Of HUMIRA (RTTNews)
06.10.14	AbbVie's Humira Gets FDA Approval For Extension Of Polyarticular JIA (RTTNews)
29.09.14	AMBI Snapped Up, ALIM's Iluvien Gets FDA Nod, GLYC Faces Glitch In Study (RTTNews)
27.09.14	AbbVie Presents Results From Studies Of Investigational Compound Veliparib (RTTNews)
25.09.14	AbbVie's HUMIRA Gets U.S. FDA Approval For Treatment Of Pediatric Patients (RTTNews)
20.09.14	Horizon Pharma Moves To Ireland Even As US Lawmakers Threat Looms (RTTNews)
11.09.14	AbbVie's Phase 3 Trial Of Humira Meets Primary Endpoint - Quick Facts (RTTNews)
09.09.14	FTC Sues AbbVie For Illegally Blocking Generic Version Of AndroGel (RTTNews)
04.09.14	AbbVie Cuts GAAP Outlook Due To Collaboration Deals With Calico, Infinity (RTTNews)
03.09.14	Infinity Stock Soars On Cancer Drug Collaboration With AbbVie (RTTNews)
03.09.14	Infinity And AbbVie Collaborate To Develop & Commercialize Duvelisib In Oncology (RTTNews)
05.08.14	CBMG Does A Deal, FLML Brightening Up, MusclePharm In Shape, Watch Out For NPSP (RTTNews)
25.07.14	AbbVie Q2 Profit Rises, Results Beat View; Affirms 2014 Outlook (RTTNews)
25.07.14	AbbVie Q2 Results Beat Estimates - Quick Facts (RTTNews)
25.07.14	Earnings Watch For July 25 (TYC, XRX, AON, LEA) (RTTNews)
18.07.14	Shire Q2 Profit Climbs, Lifts FY14 Growth Forecast - Update (RTTNews)
18.07.14	Shire Q2 Profit Rises; Increases Guidance - Quick Facts (RTTNews)
18.07.14	AbbVie, Shire Agree On Terms Of Merger (RTTNews)
18.07.14	AbbVie To Acquire Shire In Cash & Shares - Quick Facts (RTTNews)
18.07.14	AbbVie, Shire Likely To Announce $53 Bln Merger Friday: Reports (RTTNews)
12.07.14	Shire Confirms Talks With AbbVie - Update (RTTNews)
09.07.14	AbbVie Says Did Not Get Any Written Commitments Of Support For Its Bid For Shire (RTTNews)
08.07.14	Shire To Consider Revised AbbVie Proposal - Quick Facts (RTTNews)
08.07.14	AbbVie Again Sweetens Takeover Offer For Shire (RTTNews)
08.07.14	AbbVie Increases Bid For Shire To Indicative Value Of £51.15/Shr - Quick Facts (RTTNews)
26.06.14	AbbVie Begins Phase III Trial Of Veliparib For Advanced Breast Cancer (RTTNews)
23.06.14	AbbVie Lifts Full Year EPS Outlook - Update (RTTNews)
23.06.14	AbbVie Raises Full-year 2014 EPS Guidance - Quick Facts (RTTNews)
20.06.14	Bloomberg: AbbVie Mulls Another Sweetened Offer For Shire (RTTNews)
20.06.14	AbbVie Considers Raising Takeover Offer For Shire : Report (RTTNews)
20.06.14	Shire Rejects AbbVie's Merger Proposal, Stock Climbs - Update (RTTNews)
20.06.14	Shire Confirms Rejection Of AbbVie Proposal - Quick Facts (RTTNews)
16.06.14	Biogen Idec, AbbVie Announce Positive Results From Phase 3 DECIDE Clinical Trial (RTTNews)
11.06.14	OraSure And AbbVie To Co-promote OraQuick HCV Rapid Test In U.S. - Quick Facts (RTTNews)
31.05.14	Seattle Genetics Reports Data From Collaborator ADC Programs - Quick Facts (RTTNews)
30.05.14	AbbVie To Continue Study Of ABT-414 For Glioblastoma Multiforme Brain Cancer (RTTNews)
23.05.14	EDAP Confirms FDA Panel Date, ISIS Reports Data, RedHill Touches New Peak (RTTNews)
19.05.14	Bristol-Myers, AbbVie Say Elotuzumab Gets FDA Breakthrough Therapy Designation (RTTNews)
25.04.14	AbbVie Q1 Results Beat Estimates On Strong Humira Sales, Backs FY View - Update (RTTNews)
25.04.14	AbbVie Q1 Profit Rises, Results Top Estimates; Backs 2014 Outlook - Quick Facts (RTTNews)
22.04.14	AbbVie Submits NDA To FDA For Investigational, All-Oral, Interferon-Free Therapy (RTTNews)
16.04.14	DVAX Moves On, GSK Gets FDA Nod, HART-Warming, ZGNX Gains On Favorable Ruling (RTTNews)
15.04.14	AbbVie Begins Phase III Trial Of Veliparib For NSCLC Patients (RTTNews)
12.04.14	AbbVie To Present TURQUOISE-II Study Results At ILC (RTTNews)
11.04.14	AbbVie To Present Results From SAPPHIRE-I Study At International Liver Congress (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	28.46	2.63 %	K V
Swiss Life Hldg	712.60	1.86 %	K V
Part Grp Hldg	1’245.50	1.26 %	K V
Zurich Insur Gr	545.00	1.15 %	K V
Swiss Re	132.70	1.14 %	K V
Givaudan	3’945.00	-0.53 %	K V
Geberit	511.20	-0.66 %	K V
Alcon	76.38	-0.68 %	K V
Sika	212.90	-1.34 %	K V
CieFinRichemont	134.25	-2.65 %	K V

mehr

11.11.24		Börse New York in Grün: S&P 500 zum Handelsende freundlich
11.11.24		Optimismus in New York: S&P 500 am Nachmittag mit Kursplus
11.11.24		NYSE-Handel: S&P 500 mittags freundlich
11.11.24		Freundlicher Handel: Börsianer lassen S&P 500 zum Start des Montagshandels steigen
02.07.24		Freundlicher Handel: S&P 500 verbucht zum Handelsende Zuschläge
02.07.24		Schwacher Handel in New York: S&P 500 beginnt die Sitzung mit Verlusten
06.05.24		S&P 500-Titel AbbVie-Aktie: Mit dieser Dividende bereitet AbbVie Aktionären eine Freude
26.04.24		Gewinne in New York: S&P 500 am Nachmittag fester

11.11.24

Börse New York in Grün: S&P 500 zum Handelsende freundlich

11.11.24

Optimismus in New York: S&P 500 am Nachmittag mit Kursplus

11.11.24

NYSE-Handel: S&P 500 mittags freundlich

11.11.24

Freundlicher Handel: Börsianer lassen S&P 500 zum Start des Montagshandels steigen

02.07.24

Freundlicher Handel: S&P 500 verbucht zum Handelsende Zuschläge

02.07.24

Schwacher Handel in New York: S&P 500 beginnt die Sitzung mit Verlusten